Kara, M. Et Al. 2020. Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors.. Endocrine pathology , vol.31, no.2 , 166-173.

Kara, M., Tokat, F., Pamir, M. N., & Danyeli, A., (2020). Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors.. Endocrine pathology , vol.31, no.2, 166-173.

Kara, Müjdat Et Al. "Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors.," Endocrine pathology , vol.31, no.2, 166-173, 2020

Kara, Müjdat Et Al. "Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors.." Endocrine pathology , vol.31, no.2, pp.166-173, 2020

Kara, M. Et Al. (2020) . "Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors.." Endocrine pathology , vol.31, no.2, pp.166-173.

@article{article, author={Müjdat KARA Et Al. }, title={Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors.}, journal={Endocrine pathology}, year=2020, pages={166-173} }